CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-09 | Sabag Mark EVP, International Markets | Option exercise | +15,523 | 74,005 | ||
| 2022-02-09 | Sabag Mark EVP, International Markets | Option exercise · Restricted Share Units | −15,523 | 0 | ||
| 2022-02-09 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise | +16,121 | 57,532.51 | ||
| 2022-02-09 | Fridriksdottir Hafrun Executive VP, Global R&D | Sale | −6,116 | $9.06 | $55K | 51,416.51 |
| 2022-02-09 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise · Restricted Share Units | −16,121 | 0 | ||
| 2022-02-09 | Drape Eric Executive VP Global Operations | Option exercise | +6,568 | 39,696 | ||
| 2022-02-09 | Drape Eric Executive VP Global Operations | Sale | −3,583 | $9.06 | $32K | 36,113 |
| 2022-02-09 | Drape Eric Executive VP Global Operations | Option exercise · Restricted Share Units | −6,568 | 0 | ||
| 2022-02-09 | Dethlefs Sven EVP, North America Commercial | Option exercise | +13,135 | 91,111 | ||
| 2022-02-09 | Dethlefs Sven EVP, North America Commercial | Sale | −4,138 | $9.06 | $37K | 86,973 |
| 2022-02-09 | Dethlefs Sven EVP, North America Commercial | Option exercise · Restricted Share Units | −13,135 | 0 | ||
| 2022-02-09 | Daniell Richard Exec. VP, European Commercial | Option exercise | +13,135 | 33,415 | ||
| 2022-02-09 | Daniell Richard Exec. VP, European Commercial | Sale | −13,135 | $9.06 | $119K | 20,280 |
| 2022-02-09 | Daniell Richard Exec. VP, European Commercial | Option exercise · Restricted Share Units | −13,135 | 0 | ||
| 2022-02-08 | Stark David Matthew Exec. VP Chief Legal Officer | Grant or award · Restricted Share Units | +37,939 | 37,939 | ||
| 2022-02-08 | Schultz Kare President and CEO | Grant or award · Restricted Share Units | +162,593 | 162,593 | ||
| 2022-02-08 | Sabag Mark EVP, International Markets | Grant or award · Restricted Share Units | +43,358 | 43,358 | ||
| 2022-02-08 | Fridriksdottir Hafrun Executive VP, Global R&D | Grant or award · Restricted Share Units | +51,488 | 51,488 | ||
| 2022-02-08 | Drape Eric Executive VP Global Operations | Grant or award · Restricted Share Units | +32,518 | 32,518 | ||
| 2022-02-08 | Dethlefs Sven EVP, North America Commercial | Grant or award · Restricted Share Units | +37,939 | 37,939 |
Page 42 of 76 · 1,517 trades